Core Insights - The core viewpoint of the articles highlights the impressive performance of Jianhe Group's China operations under CEO Li Fengting, particularly in the context of the company's recent financial results for Q3 2025 [1][3]. Group 1: Company Performance - Jianhe Group reported total revenue of 10.805 billion in the first three quarters of 2025, representing a year-on-year growth of 12.3% [3]. - Revenue from the Chinese market grew by 20.6%, increasing its contribution to total revenue from 65.9% in the previous year to 71.0%, with approximately 7.7 billion in revenue [3]. - The adult nutrition and care segment in China saw a growth of 15.7%, while the pet nutrition and care segment grew by 8.0%, and sales of infant formula increased by 35.2% [4]. Group 2: Leadership and Strategy - Li Fengting, who graduated from Zhejiang University in 2008, has held various positions in Procter & Gamble before joining Jianhe Group in 2018, eventually becoming the CEO of the China operations in 2023 [3][4]. - Upon taking office, Li set a revenue target of 10 billion for 2023 and 12 billion for 2025, which was a significant reduction from the previous target of 20 billion set by her predecessor [3]. - Despite a conservative target, the 2023 revenue of 9.973 billion fell slightly short of the 10 billion goal [3].
健合集团中国区CEO李凤婷上任两年后业绩亮眼 比前任安玉婷干得好？